SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Eli Lilly Says Olomorasib Shows Durable Efficacy in Lung Cancer Studies

Eli Lilly said new trial data showed olomorasib had durable efficacy in non-small cell lung cancer studies.

LLY

Related stories